- Home
- FORR vs ENTA Comparison
FORR vs ENTA Comparison
Compare FORR & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORR
- ENTA
- Stock Information
- Founded
- FORR 1983
- ENTA 1995
- Country
- FORR United States
- ENTA United States
- Employees
- FORR N/A
- ENTA N/A
- Industry
- FORR Diversified Commercial Services
- ENTA Biotechnology: Pharmaceutical Preparations
- Sector
- FORR Consumer Discretionary
- ENTA Health Care
- Exchange
- FORR Nasdaq
- ENTA Nasdaq
- Market Cap
- FORR 193.5M
- ENTA 160.3M
- IPO Year
- FORR 1996
- ENTA 2013
- Fundamental
- Price
- FORR $10.53
- ENTA $7.65
- Analyst Decision
- FORR
- ENTA Buy
- Analyst Count
- FORR 0
- ENTA 4
- Target Price
- FORR N/A
- ENTA $18.00
- AVG Volume (30 Days)
- FORR 73.4K
- ENTA 178.6K
- Earning Date
- FORR 07-29-2025
- ENTA 08-04-2025
- Dividend Yield
- FORR N/A
- ENTA N/A
- EPS Growth
- FORR N/A
- ENTA N/A
- EPS
- FORR N/A
- ENTA N/A
- Revenue
- FORR $422,269,000.00
- ENTA $64,462,999.00
- Revenue This Year
- FORR N/A
- ENTA N/A
- Revenue Next Year
- FORR $2.04
- ENTA $0.48
- P/E Ratio
- FORR N/A
- ENTA N/A
- Revenue Growth
- FORR N/A
- ENTA N/A
- 52 Week Low
- FORR $8.50
- ENTA $4.09
- 52 Week High
- FORR $20.62
- ENTA $17.24
- Technical
- Relative Strength Index (RSI)
- FORR 56.84
- ENTA 60.48
- Support Level
- FORR $9.46
- ENTA $6.95
- Resistance Level
- FORR $9.93
- ENTA $8.23
- Average True Range (ATR)
- FORR 0.43
- ENTA 0.38
- MACD
- FORR 0.09
- ENTA -0.01
- Stochastic Oscillator
- FORR 72.83
- ENTA 57.44
About FORR Forrester Research Inc.
Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.